ANL 13.19 Increased By ▲ 0.65 (5.18%)
ASC 12.17 Decreased By ▼ -0.53 (-4.17%)
ASL 13.50 Increased By ▲ 0.04 (0.3%)
BOP 8.31 Decreased By ▼ -0.07 (-0.84%)
BYCO 5.75 Decreased By ▼ -0.21 (-3.52%)
FCCL 17.06 Decreased By ▼ -0.02 (-0.12%)
FFBL 23.61 Decreased By ▼ -0.44 (-1.83%)
FFL 10.05 Increased By ▲ 0.08 (0.8%)
FNEL 9.31 Increased By ▲ 0.06 (0.65%)
GGGL 13.80 Decreased By ▼ -0.20 (-1.43%)
GGL 26.75 Decreased By ▼ -0.30 (-1.11%)
HUMNL 5.66 Decreased By ▼ -0.07 (-1.22%)
JSCL 14.55 Decreased By ▼ -0.45 (-3%)
KAPCO 30.70 Decreased By ▼ -0.90 (-2.85%)
KEL 3.16 Decreased By ▼ -0.06 (-1.86%)
MDTL 2.09 Decreased By ▼ -0.12 (-5.43%)
MLCF 31.90 Decreased By ▼ -0.85 (-2.6%)
NETSOL 89.00 Decreased By ▼ -1.21 (-1.34%)
PACE 4.09 Decreased By ▼ -0.01 (-0.24%)
PAEL 20.42 Decreased By ▼ -0.09 (-0.44%)
PIBTL 7.27 Increased By ▲ 0.02 (0.28%)
POWER 6.31 Decreased By ▼ -0.08 (-1.25%)
PRL 11.80 Decreased By ▼ -0.15 (-1.26%)
PTC 8.69 Decreased By ▼ -0.11 (-1.25%)
SILK 1.19 Increased By ▲ 0.02 (1.71%)
SNGP 37.10 Decreased By ▼ -0.60 (-1.59%)
TELE 14.47 Decreased By ▼ -0.38 (-2.56%)
TRG 79.19 Increased By ▲ 1.51 (1.94%)
UNITY 21.85 Decreased By ▼ -1.05 (-4.59%)
WTL 2.00 Decreased By ▼ -0.03 (-1.48%)
BR100 4,398 Increased By ▲ 17.1 (0.39%)
BR30 16,992 Increased By ▲ 128.7 (0.76%)
KSE100 43,281 Increased By ▲ 47.9 (0.11%)
KSE30 16,777 Increased By ▲ 59.2 (0.35%)

Coronavirus
LOW Source: covid.gov.pk
Pakistan Deaths
28,777
1024hr
Pakistan Cases
1,287,161
33624hr
Sindh
476,830
Punjab
443,519
Balochistan
33,507
Islamabad
107,930
KPK
180,383

THE HAGUE: The Pfizer/BioNTech coronavirus jab got the green light for children aged five to 11 in Europe on Thursday, clearing the way for the vaccination in a cohort where the virus is rapidly spreading.

The European Medicines Agency (EMA) said that a panel of experts "recommended granting an extension of indication for the Covid-19 vaccine Comirnaty to include use in children aged five to 11", using the jab's brand name.

The vaccine is already cleared for use in people aged 12 and over in the 27-nation EU.

Pfizer's jab is has so far only been approved in a small number of countries for children aged five to 11 in countries including the United States, Israel and Canada.

Children aged five to 11 will be given one third of the dose that older people receive, with two injections, three weeks apart, the EMA said.

The vaccine was 90.7 percent effective in a study of nearly 2,000 children of that age, it added. Side effects were usually "mild or moderate" lasting for few days, and included pain in the injection site, tiredness, headache, muscle pain and chills.

US gives final approval of Pfizer's Covid vaccine for children aged 5-11

The EMA "therefore concluded that the benefits of Comirnaty in children aged five to 11 outweigh the risks, particularly in those with conditions that increase the risk of severe Covid-19."

In the Netherlands, where the EMA is based, authorities said earlier this week that the largest increase in cases was among children up to the age of 12.

The regulator has so far approved four vaccines for use in the EU: Pfizer and Moderna, which use messenger RNA technology, and AstraZeneca and Johnson & Johnson, which use viral vector technology.

We love hearing your feedback, please help us improve by answering these few survey questions

Comments

Comments are closed.